KORU Medical Systems vs Myomo
KORU Medical Systems reported revenue of $41 million in fiscal 2025, about the same as Myomo's $41 million in fiscal 2025. KORU Medical Systems' revenue grew 22.2% in its latest year, and Myomo's grew 25.7%. KORU Medical Systems had an operating margin of -7.2%, against -35.2% at Myomo. Free cash flow was −$0 million at KORU Medical Systems and −$16 million at Myomo.
Side by side
| KORU Medical Systems | Myomo | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $41M | $41M |
| Revenue growth | 22.2% | 25.7% |
| Revenue growth a year, last 5 years | 11.2% | 40.0% |
| Gross margin | 62.3% | 65.7% |
| Operating margin | −7.2% | −35.2% |
| Net margin | −6.4% | −38.0% |
| Free cash flow | −$0M | −$16M |
| Free cash flow margin | −1.1% | −39.7% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 0.8% | 10.8% |
| Last close | $3.44 | $0.84 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $241,615, sold $0 | bought $439,324, sold $102,893 |
| Piotroski F-score | — | 3 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
KORU Medical SystemsMyomo
Operating margin
Percent of revenue
KORU Medical SystemsMyomo
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
KORU Medical SystemsMyomo
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the KORU Medical Systems and Myomo pages.